Meningococcal B vaccination: real-world experience and future perspectives

Meningococcal vaccines: past, present, and future perspectives

Meningococcal disease remains a significant global public health issue and is unique among causes of bacterial meningitis and sepsis where not only does it cause sporadic disease but also outbreaks. The prevention of meningococcal disease also presents a serious challenge . Although polysaccharide vaccines have been available for serogroup A, C, Y, and W135 for many years, serogroup C polysacch...

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

Neisseria meningitidis is a Gram-negative pathogen that actively invades its human host and leads to the development of life-threatening pathologies. One of the leading causes of death in the world, N. meningitidis can be responsible for nearly 1,000 new infections per 100,000 subjects during an epidemic period. The bacterial species are classified into 12 serogroups, five of which (A, B, C, W,...

Meningococcal B vaccination strategies and their practical application in Italy

Immunisation against meningococcal meningitis has a long history, which has passed through several phases: the studies by Flexner, extraction of the polysaccharide capsule, the development of monovalent and multivalent conjugate vaccines, the outer membrane vesicle vaccines up to the development of effective and safe vaccines for meningococcal B invasive disease through the application of the t...

Robotic Cholecystectomy: Preliminary Experience and Future Perspectives

Background: The main advantages of robotics in general surgery may be for advanced minimally invasive procedures. Unlike other specialties, formal fellowship training opportunities for robotic general surgery are few. As a result, most surgeons currently develop robotic skills in practice and robotic cholecystectomy represents the operation of choice for general surgeons to acquire clinical da ...

Membrane Engineering: Future Perspectives